Opsoclonus-Myoclonus Syndrome in a Child with Birth Asphyxia

Article Sidebar

26-Jun-5480.pdf
Published Jul 1, 2024

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Subhashchandra Daga
Honorary Pediatrician, Primary Health Center, Kamshet 410405. India.
http://orcid.org/0000-0001-5840-3804

Abstract

A case of Opsoclonus Myoclonus Syndrome associated with birth asphyxia presented with antiseizure treatment started soon after birth and continued after discharge. The child presented at two years of age and had jerky movements in the limbs and eyes. The eye movements promptly responded to phenobarbital, and the limb movements appreciably diminished after adding clonazepam. The practice of continuing antiseizure treatment post-discharge in asphyxiated babies is questionable. No asphyxiated baby is reported in the literature to have OMS.

Keywords: Opsoclonus-Myoclonus Syndrome, Birth Asphyxia, Antiseizure Treatment, Phenobarbital, Clonazepam, Pediatric Neurology, Jerky Movements, Neonatal Asphyxia

Article Details

How to Cite
DAGA, Subhashchandra. Opsoclonus-Myoclonus Syndrome in a Child with Birth Asphyxia. Medical Research Archives, [S.l.], v. 12, n. 6, july 2024. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/5480>. Date accessed: 02 july 2024.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Issue
Vol 12 No 6 (2024): Vol 12 No 6 (2024): JUNE issue, Issue 6, VOl.12
Section
Case Reports

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.

 

References

1. Susumu Ito, Kaoruko Nagumo, Aiko Nishikawa, Hirokazu Oguni, Satoru Nagata. Low-dose phenobarbital for epilepsy with myoclonic absences: A case report. Brain and Development 2021; 43:666-8.

2. Bhatia P, Heim J, Cornejo P, Kane L, Santiago J, Cruer M. Opsoclonus–myoclonus–ataxia syndrome in children. Journal of Neurology 2022; 269:750–757.

3. Krug P, Schleiermacher G, Hichon J, Valteau-Counet D, Brisse H. Opsoclonus-myoclonus in children associated or not with neuroblastoma. European Journal of Paediatric Neurology 2010;14: 400-409.

4. Sewell EK, Shankaran S, McDonald SA, et al. Antiseizure medication at discharge in infants with hypoxic-ischaemic encephalopathy: an observational study. Arch Dis Child Fetal Neonatal Ed 2023; 108:421–8.

5. Hunt RW. Neonatal seizures. Treat! But when, with what, and for how long? Arch Dis Child Fetal Neonatal Ed 2023;108: F552– F553.

6. Glass HC, Soul JS, Chang T, et al. Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol 2021; 78:817–25.